Protocol 15-0020: targeted reduction of antibiotics using procalcitonin in a multi-center, randomized, blinded, placebo-controlled non-inferiority study of azithromycin treatment in outpatient…
Ended Awarded Last action
- Contract number
- HHSN27200009
- Awardee
-
Baylor College Of Medicine UEI FXKMA43NTV21
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $850,632
Award facts
- Opportunity
-
- NIAIDDMIDNIHAI2012144 Solicitation number
- Vaccine and treatment evaluation units (vteu) Award Notice · Posted Mar 29, 2012
- Contract value 100% obligated
- $850,632.27 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- Houston, TX 77030, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$142,280 | |
| Supplemental Agreement for work within scope | -$20,066 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $272,626 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $117,640 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $183,112 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $203,024 | |
| Other Administrative Action | $0 | |
| Change Order | $185,014 | |
| Original award | $51,562 |
Show all 14
About this award
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a part of the U.S. Department of Health and Human Services, to Baylor College of Medicine, a private health sciences university in Houston, Texas. The contract has an award value of $850,632.27 and is for a clinical trial to evaluate the use of procalcitonin to guide the targeted reduction of antibiotics in the treatment of suspect lower respiratory tract infections in outpatient adults. This contract is a delivery order under the NIAID's Vaccine and Treatment Evaluation Units (VTEU) indefinite delivery vehicle, which supports biomedical research and clinical trials related to infectious diseases and vaccines. The contract does not have a set-aside designation, indicating that Baylor College of Medicine was competitively selected for this award based on its expertise and qualifications as a leading academic medical center.
Description
Protocol 15-0020: targeted reduction of antibiotics using procalcitonin in a multi-center, randomized, blinded, placebo-controlled non-inferiority study of azithromycin treatment in outpatient adults with suspect lower respiratory tract infection (lrti) and a procalcitonin level of
Quick answers
Who was awarded contract HHSN27200009?
HHSN27200009 was awarded to Baylor College Of Medicine by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on June 14, 2016.
How much is contract HHSN27200009 worth?
The government has obligated $850,632 on HHSN27200009.
Is contract HHSN27200009 an order under another contract?
Yes. HHSN27200009 is a delivery order under HHSN272201300015I, an indefinite delivery contract, on Vaccine and Treatment Evaluation Units (VTEU).
Was contract HHSN27200009 competed?
The extent of competition for HHSN27200009 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award